Artículos por temáticas

Stem cell therapy for Parkinson's disease: safety and modeling

Stoddard-Bennett T, Pera RR.

Neural Regen Res. 2020 Jan;15(1):36-40. doi: 10.4103/1673-5374.264446.

Letter to the editor: Is polygenic risk for Parkinson's disease associated with less risk of first episode psychosis?

Quattrone D, Richards A, Reininghaus U, Vassos E, O'Donovan M, Lewis C, Di Forti M.

Psychol Med. 2020 Jan;50(1):173-176. doi: 10.1017/S0033291719002435. Epub 2019 Sep 19.

Pharmacological targeting of β(2) -adrenoceptors is neuroprotective in the LPS inflammatory rat model of Parkinson's disease

O'Neill E, Yssel JD, McNamara C, Harkin A.

Br J Pharmacol. 2020 Jan;177(2):282-297. doi: 10.1111/bph.14862. Epub 2019 Dec 12.

Association between fatigue and motor progression in Parkinson's disease in southern Chinese

Yu HX, Guo MR, Li G, Zhang B.

Neurol Sci. 2020 Jan;41(1):161-164. doi: 10.1007/s10072-019-04059-z. Epub 2019 Sep 4.

Understanding the links between cardiovascular disease and Parkinson's disease

Potashkin J, Huang X, Becker C, Chen H, Foltynie T, Marras C.

Mov Disord. 2020 Jan;35(1):55-74. doi: 10.1002/mds.27836. Epub 2019 Sep 4.

Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease

Parra I, Martínez I, Ramírez-García G, Tizabi Y, Mendieta L.

Neurotox Res. 2020 Jan;37(1):1-11. doi: 10.1007/s12640-019-00104-z. Epub 2019 Sep 2.

Functional Motor Symptoms in Parkinson's Disease and Functional Parkinsonism: A Systematic Review.

Ambar Akkaoui M, Geoffroy PA, Roze E, Degos B, Garcin B.

J Neuropsychiatry Clin Neurosci. 2020 Winter;32(1):4-13. doi: 10.1176/appi.neuropsych.19030058. Epub 2019 Aug 30.

Home-based monitoring of falls using wearable sensors in Parkinson's disease

Silva de Lima AL, Smits T, Darweesh SKL, Valenti G, Milosevic M, Pijl M, Baldus H, de Vries NM, Meinders MJ, Bloem BR.

Mov Disord. 2020 Jan;35(1):109-115. doi: 10.1002/mds.27830. Epub 2019 Aug 26.

A neurophysiological investigation of anticipation to pain in Parkinson's disease

Martin SL, Jones AKP, Brown CA, Kobylecki C, Silverdale MA.

Eur J Neurosci. 2020 Jan;51(2):611-627. doi: 10.1111/ejn.14559. Epub 2019 Sep 13.

Rasagiline combined with levodopa therapy versus levodopa monotherapy for patients with Parkinson's disease: a systematic review

Jiang DQ, Wang HK, Wang Y, Li MX, Jiang LL, Wang Y.

Neurol Sci. 2020 Jan;41(1):101-109. doi: 10.1007/s10072-019-04050-8. Epub 2019 Aug 24.

Risk thresholds of levodopa dose for dyskinesia in Chinese patients with Parkinson's disease: a pilot study

Liu G, Chen H, Su D, Wang D, Zhang M, Wang X, Wang Z, Yang Y, Jiang Y, Ma H, Feng T.

Neurol Sci. 2020 Jan;41(1):111-118. doi: 10.1007/s10072-019-04043-7. Epub 2019 Aug 24.

The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease

Han QW, Yuan YH, Chen NH.

Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109745. doi: 10.1016/j.pnpbp.2019.109745. Epub 2019 Aug 20.

Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease

Jarras H, Bourque M, Poirier AA, Morissette M, Coulombe K, Di Paolo T, Soulet D.

J Neuroendocrinol. 2020 Jan;32(1):e12782. doi: 10.1111/jne.12782. Epub 2019 Sep 10.

Early Postnatal Exposure to Paraquat and Maneb in Mice Increases Nigrostriatal Dopaminergic Susceptibility to a Re-challenge with the Same Pesticides at Adulthood: Implications for Parkinson's Disease

Colle D, Santos DB, Naime AA, Gonçalves CL, Ghizoni H, Hort MA, Farina M.

Neurotox Res. 2020 Jan;37(1):210-226. doi: 10.1007/s12640-019-00097-9. Epub 2019 Aug 17.

The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease

Ghadery C, Koshimori Y, Christopher L, Kim J, Rusjan P, Lang AE, Houle S, Strafella AP.

Mol Neurobiol. 2020 Jan;57(1):492-501. doi: 10.1007/s12035-019-01714-6. Epub 2019 Aug 5.